SYMBRAVO

meloxicam; rizatriptan · Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYMBRAVO, covering 2025-01-30 to 2025-01-30. Get the full timeline:

Most recent: FDA Approved: SYMBRAVO — Original Application (Axsome Therapeutics, Inc.)